“…in rheumatoid synovial tissue [34–36] and among infiltrating mononuclear cells of MS patient brain lesions [37]). Reduced peripheral NK cell activities and, in some studies, also differences in NK cell numbers are found when patients suffering from various autoimmune syndromes, such as remitting/relapsing (r/r) MS [38–42], Sjögren's Syndrome (SS) [41, 43–45], MG [46], rheumatoid arthritis (RA) [47–50], SLE [43, 47, 51, 52] and type 1 diabetes [53–56], are studied and compared with controls. It has, however, been difficult to determine whether these qualitative and quantitative alterations stem from metabolic disturbances, the therapy used or whether they represent a primary NK cell defect that could have played a pathogenic role [55–60].…”